Hepatitis B surface antigen seroclearance is uncommon but durable in the long run - PubMed (original) (raw)

Comment

. 2024 Jun 1;79(6):1258-1260.

doi: 10.1097/HEP.0000000000000741. Epub 2023 Dec 25.

Affiliations

Comment

Hepatitis B surface antigen seroclearance is uncommon but durable in the long run

Terry Cheuk-Fung Yip et al. Hepatology. 2024.

No abstract available

Rate and durability of the clearance of HBsAg in Alaska Native persons with long-term HBV infection: 1982-2019.
Bruden D, McMahon BJ, Snowball M, Towshend-Bulson L, Homan C, Johnston JM, Simons BC, Bruce MG, Cooley L, Spradling PR, Harris AM. Bruden D, et al. Hepatology. 2024 Jun 1;79(6):1412-1420. doi: 10.1097/HEP.0000000000000658. Epub 2023 Nov 7. Hepatology. 2024. PMID: 37939079 Free PMC article.

1. Yip TC, Wong VW, Lai MS, Lai JC, Hui VW, Liang LY, et al. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss. J Hepatol. 2023;78:524–533.
1. Song A, Wang X, Lu J, Jin Y, Ma L, Hu Z, et al. Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis. J Viral Hepat. 2021;28:601–612.
1. Bruden D, McMahon BJ, Snowball M, Towshend-Bulson L, Homan C, Johnston JM, et al. Rate and durability of clearance of hepatitis B surface antigen in Alaska native persons with long-term hepatitis B virus infection: 1982-2019. Hepatology. 2023. doi:10.1097/HEP.0000000000000658 - DOI
1. Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, et al. Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: A systematic review and meta-analysis. Gastroenterology. 2019;156:635–646. e639.
1. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up. Hepatology. 2007;45:1187–1192.